New drug BLKR201 put to the test in healthy volunteers

NCT ID NCT07501039

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study is testing whether a new drug called BLKR201 is safe for people. About 128 healthy adults will take either the drug or a placebo and stay at a research clinic for several days. Researchers will monitor side effects, measure how the drug moves through the body, and check if food changes its absorption. This study does not aim to treat any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Celerion

    RECRUITING

    Lincoln, Nebraska, 68502, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.